Alzheimer’s Disease/Dementia News

SAN DIEGO — In older adult patients with Alzheimer’s-related dementia, treatment with brexpiprazole resulted in greater reduction in agitation compared with placebo, while proving to be safe and well-tolerated.

The University of New Hampshire announced it will receive a 5-year, $2.8 million grant from NIH to develop and test social assistive robots to elevate at-home care for people with Alzheimer’s disease and dementia.

Atrial cardiopathy was associated with increased risk for dementia, according to new data from the ARIC cohort study.

A neurotoxin derived from bacteria in the gastrointestinal tract has been identified as a major contributor to Alzheimer’s disease, researchers reported in Frontiers in Neurology.

Associations between cognitive ability in childhood and cognitive state in older age are moderated by how active and enriching one’s lifestyle remains through the middle years, according to a study published in Neurology.

Data from a genetics-based study show PCSK9 inhibition does not affect cognition function or dementia risk; however, statin use may be associated with some impaired cognitive performance that is outweighed by any CV benefits.

SAN DIEGO — Decline in dementia risk for Latino populations compared with white counterparts is associated with level of education across generations, a presenter said at the Alzheimer’s Association International Conference.

Atrial fibrillation conferred elevated risk for dementia in adults younger than 70 years, according to study findings published in the Journal of the American Heart Association.

The FDA has declined to approve a supplemental new drug application for the expanded use of Nuplazid to treat psychosis related to Alzheimer's disease.

SAN DIEGO — With prevalence of age-related cognitive decline and limited curative treatment options, nutritional interventions may prevent or delay symptom onset, per a presenter at the Alzheimer’s Association International Conference.